Skip to main content

What the FDA labels say about taking them together

Digoxin and piroxicam

Piroxicam's FDA label of August 19, 2026 names digoxin in its drug interactions section; the digoxin labels PlainMeds reads (3) do not name piroxicam. The piroxicam label: “The concomitant use of piroxicam with digoxin has been reported to increase the serum concentration and prolong the half-life of digoxin.”

Check it at the source: the digoxin FDA label on DailyMed (effective December 5, 2024, Advanz Pharma (US) Corp.); the piroxicam FDA label on DailyMed (effective August 19, 2026, Teva Pharmaceuticals USA, Inc.).

What does the digoxin label say about piroxicam?

Digoxin's label (effective December 5, 2024) and its 2 other brand-application labels do not name piroxicam in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (LANOXIN), Advanz Pharma (US) Corp., effective December 5, 2024 (SPL set d91e3646-4c63-4512-ab22-db39c085c4dc), via openFDA; the full label on DailyMed

What does the piroxicam label say about digoxin?

Piroxicam label, drug interactions

Clinical Impact: The concomitant use of piroxicam with digoxin has been reported to increase the serum concentration and prolong the half-life of digoxin. Intervention: During concomitant use of piroxicam and digoxin, monitor serum digoxin levels.

Source: FDA drug label (Piroxicam), Teva Pharmaceuticals USA, Inc., effective August 19, 2026 (SPL set f1123fe1-b79c-430b-8548-08cd6e518482), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

26Digoxin generic labelers
10Piroxicam generic labelers
DigoxinPiroxicam
Labeled forHeart failure, Atrial fibrillationOsteoarthritis, Rheumatoid arthritis
Boxed warningNoYes
Pharmacy cost (NADAC)$0.133 per tablet 125 mcg tablet$0.215 per capsule 20 mg capsule
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?